• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mechanism of time-dependent inhibition of 5 alpha-reductases by delta 1-4-azasteroids: toward perfection of rates of time-dependent inhibition by using ligand-binding energies.

作者信息

Tian G, Mook R A, Moss M L, Frye S V

机构信息

Division of Biochemistry, Glaxo Wellcome Research Institute, Research Triangle Park, North Carolina 27709, USA.

出版信息

Biochemistry. 1995 Oct 17;34(41):13453-9. doi: 10.1021/bi00041a024.

DOI:10.1021/bi00041a024
PMID:7577933
Abstract

Finasteride (17 beta-N-tert-butylcarbamoyl-4-aza-5 alpha-androstan-1-en-3- one) is a time-dependent, apparently irreversible inhibitor of 5 alpha-reductases, but does not fully inhibit the activity of 5 alpha-reductase in vivo. This limited efficacy has been attributed to its slow rate of inhibition against the type-1 isozyme [Tian, G. (1995) J. Pharm. Sci. (in press)]. Here the feasibility of increasing the rate of inhibition of 5 alpha-reductases by providing binding energies with the inhibitor at a site remote from the center of chemical transformation was explored. Substitution of N-(2,5-bis(trifluoromethyl)phenyl) group, which had been shown to benefit 6-azasteroids in the binding to 5 alpha-reductases [Frye, S., Haffner, C. D., Maloney, P. R., Hiner, R. N., Unwalla, R. J., Batchelor, K. W., Bramson, H. N., Stuart, J. D., Schweiker, S. L., Van Arnold, J., Bickett, D. M., Moss, M. L., Tian, G., Lee, F. W., Tippin, T. K., James, M. K., Grizzle, M. K., Long, J. E., & Croom, D. K. (1995) J. Med. Chem. 38, 2621-2627], for the N-tert-butyl substituent at C-17 of finasteride did not perturb the mechanism of inhibition but significantly increased the rate of inhibition of type-1 5 alpha-reductase. The rate of inhibition was too fast to determine accurately when the normal substrate testosterone was used in the progress curve analysis as this inhibition rate is approaching the value of kcat/Km for the enzyme reaction.

摘要

相似文献

1
Mechanism of time-dependent inhibition of 5 alpha-reductases by delta 1-4-azasteroids: toward perfection of rates of time-dependent inhibition by using ligand-binding energies.
Biochemistry. 1995 Oct 17;34(41):13453-9. doi: 10.1021/bi00041a024.
2
Linear relationships between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5alpha-reductase by delta 1-4-azasteroids.δ1-4-氮杂甾体对甾体5α-还原酶时间依赖性抑制的配体结合能与活化能之间的线性关系。
J Biol Chem. 2001 Jun 15;276(24):21359-64. doi: 10.1074/jbc.M100793200. Epub 2001 Mar 8.
3
Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.大鼠1型和2型类固醇5α-还原酶的药代动力学参数及抑制机制:GI198745和非那雄胺在大鼠体内不同活性的决定因素
Biochem Pharmacol. 2001 Oct 1;62(7):933-42. doi: 10.1016/s0006-2952(01)00728-6.
4
17 beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 alpha-reductase 1.
Biochemistry. 1994 Mar 1;33(8):2291-6. doi: 10.1021/bi00174a041.
5
Inhibition of human steroid 5alpha reductases type I and II by 6-aza-steroids: structural determinants of one-step vs two-step mechanism.
Biochemistry. 1996 Mar 19;35(11):3457-64. doi: 10.1021/bi952472+.
6
In vivo time-dependent inhibition of human steroid 5 alpha-reductase by finasteride.非那雄胺对人甾体5α-还原酶的体内时间依赖性抑制作用。
J Pharm Sci. 1996 Jan;85(1):106-11. doi: 10.1021/js950100g.
7
A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.在不可逆5α-还原酶抑制剂GI198745和非那雄胺存在的情况下二氢睾酮周转的模型。
Clin Pharmacol Ther. 1998 Dec;64(6):636-47. doi: 10.1016/S0009-9236(98)90054-6.
8
Mechanism based representation of the active site of 5 alpha-reductase (5AR).基于机制的5α-还原酶(5AR)活性位点的表征。
Bioorg Med Chem Lett. 1998 Sep 22;8(18):2615-70. doi: 10.1016/s0960-894x(98)00463-6.
9
Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells.对在DU 145细胞中检测到并在昆虫细胞中表达的“基础”5α-还原酶(1型)活性的抑制作用。
J Steroid Biochem Mol Biol. 1994 Mar;48(4):347-52. doi: 10.1016/0960-0760(94)90074-4.
10
Inhibition of rat alpha-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition.
J Steroid Biochem Mol Biol. 1997 Apr;61(1-2):55-64. doi: 10.1016/s0960-0760(97)00002-2.

引用本文的文献

1
Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma.抑制类固醇 5α-还原酶 I 型通过 PI3K/Akt/mTOR 通路促进多发性骨髓瘤中的细胞凋亡和自噬。
Cell Death Dis. 2021 Feb 24;12(2):206. doi: 10.1038/s41419-021-03510-4.
2
Development of a Liquid Chromatography/Mass Spectrometry-Based Inhibition Assay for the Screening of Steroid 5-α Reductase in Human and Fish Cell Lines.建立一种基于液相色谱/质谱联用的抑制分析法,用于筛选人源和鱼类细胞系中的甾体 5-α 还原酶。
Molecules. 2021 Feb 8;26(4):893. doi: 10.3390/molecules26040893.
3
Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride.
人源甾体 5α-还原酶 2 与抗雄激素药物非那雄胺复合物的结构。
Nat Commun. 2020 Oct 27;11(1):5430. doi: 10.1038/s41467-020-19249-z.
4
Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride.人类固醇5α-还原酶2与抗雄激素药物非那雄胺的结构。
Res Sq. 2020 Jul 15:rs.3.rs-40159. doi: 10.21203/rs.3.rs-40159/v1.
5
The Steroidogenesis Inhibitor Finasteride Reduces the Response to Both Stressful and Rewarding Stimuli.雄激素生物合成抑制剂非那雄胺降低了对应激和奖励刺激的反应。
Biomolecules. 2019 Nov 19;9(11):749. doi: 10.3390/biom9110749.
6
Gut Microbial β-Glucuronidase Inhibition via Catalytic Cycle Interception.通过催化循环拦截抑制肠道微生物β-葡萄糖醛酸酶
ACS Cent Sci. 2018 Jul 25;4(7):868-879. doi: 10.1021/acscentsci.8b00239. Epub 2018 Jul 12.
7
Crystal structure of (20)-21-[4-(2-hy-droxy-propan-2-yl)-1-1,2,3-triazol-4-yl]-20-(4-methyl-pent-yl)-5-pregnen-3β-ol with an unknown solvate.(20)-21-[4-(2-羟基-丙烷-2-基)-1,2,3-三唑-4-基]-20-(4-甲基-戊基)-5-孕甾-3β-醇与一种未知溶剂化物的晶体结构
Acta Crystallogr E Crystallogr Commun. 2018 Mar 6;74(Pt 4):465-468. doi: 10.1107/S2056989018003286. eCollection 2018 Apr 1.
8
5α-reductase type 3 enzyme in benign and malignant prostate.良性和恶性前列腺中的 5α-还原酶 3 型酶。
Prostate. 2014 Feb;74(3):235-49. doi: 10.1002/pros.22745. Epub 2013 Oct 22.
9
Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.雄激素对前列腺癌中 5α-还原酶同工酶的调节:对前列腺癌预防的影响。
PLoS One. 2011;6(12):e28840. doi: 10.1371/journal.pone.0028840. Epub 2011 Dec 14.
10
Benign prostatic hyperplasia: An overview of existing treatment.良性前列腺增生:现有治疗方法概述。
Indian J Pharmacol. 2011 Feb;43(1):6-12. doi: 10.4103/0253-7613.75657.